health care

Healthcare M&A

CRA experts provide consultation and expert testimony analyzing the competitive effects of horizontal and vertical mergers and joint ventures across the healthcare sector. For this work, our experts account for the unique characteristics of the healthcare industry that shape competitors’ behaviors and incentives, utilize key healthcare data, and rely on sound economic theory to define product and geographic markets, assess the competitive constraints of entry and expansion, consider the impact of insurance and regulatory oversight on market dynamics, and quantify the cost reductions and quality enhancements that are only achievable through the proposed merger or joint venture.


  • 01
    Phoenix Group’s acquisition of a part of McKesson Europe cleared
    On September 30th, 2022, the French Competition Authority (ADLC) cleared the acquisition of OCP Repartition, subsidiary of McKesson Europe, by Phoenix Group...
    View engagement
  • 02
    Large multinational corporation’s acquisition of a medical device business
    Economic expert for a large multinational corporation’s acquisition of a medical device business from another multinational pharmaceutical company.
    View engagement
  • 03
    CRA assists FTC in upholding of merger complaint
    On April 29, Chief Administrative Law Judge D. Michael Chappell upheld a US Federal Trade Commission complaint challenging the consummated merger of Otto Bock...
    View engagement

Subscribe to receive our latest Insights.